C000201974 Performance — BlackRock LifePath Index 2045 Fund, Investor P
Data updated: 2026-08-25
C000201974 returned +10.45% year to date and +20.70% over one year to Jun 2026. Annualised returns are +16.89% over 3 years and +8.95% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $160, against $150 for the category, and to $121 over one year, against $118. Volatility over the past three years was 11.40% a year. In the 12 months to Jun 2026 the fund lost a net $25.8M, and assets reached $11.47B.
C000201974 Growth of $100
What $100 invested in BlackRock LifePath Index 2045 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | C000201974 | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $121 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $160 | $150 |
| 5 years (Jul 2021 – Jun 2026) | $154 | $143 |
| Since data start (Jul 2019 – Jun 2026) | $214 | $187 |
C000201974 Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +10.45% |
| 1 year | +20.70% |
| 3 years (annualised) | +16.89% |
| 5 years (annualised) | +8.95% |
C000201974 Annual Returns
Calendar-year total returns of BlackRock LifePath Index 2045 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +10.45% |
| 2025 | +18.72% |
| 2024 | +13.97% |
| 2023 | +20.00% |
| 2022 | −18.33% |
| 2021 | +17.46% |
| 2020 | +14.31% |
| 2019 (Jul–Dec) | +8.61% |
C000201974 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.7% | +2.0% | −5.5% | +7.7% | +3.7% | −0.1% | — | — | — | — | — | — |
| 2025 | +2.8% | 0.0% | −3.3% | +0.4% | +4.6% | +4.1% | +0.7% | +2.8% | +3.0% | +1.6% | +0.4% | +0.5% |
| 2024 | −0.1% | +3.6% | +3.0% | −3.9% | +4.2% | +1.6% | +2.3% | +2.3% | +2.2% | −2.3% | +3.9% | −3.2% |
| 2023 | +7.4% | −3.2% | +2.6% | +1.3% | −1.3% | +5.3% | +3.3% | −2.7% | −4.4% | −3.0% | +8.8% | +5.4% |
| 2022 | −4.4% | −2.7% | +1.6% | −7.5% | +0.2% | −7.9% | +6.9% | −4.2% | −9.4% | +5.6% | +7.9% | −4.2% |
| 2021 | −0.4% | +2.5% | +2.8% | +4.1% | +1.4% | +1.2% | +0.8% | +2.1% | −3.9% | +4.9% | −2.4% | +3.6% |
| 2020 | −1.2% | −7.2% | −14.1% | +10.0% | +4.6% | +2.9% | +4.8% | +5.5% | −2.7% | −2.2% | +11.5% | +4.6% |
| 2019 | — | — | — | — | — | — | +0.1% | −1.7% | +2.0% | +2.4% | +2.4% | +3.2% |
C000201974 Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 11.40%
- 3-year Sharpe ratio: 1.09 (vs 4.5% risk-free rate)
- Best month: +8.80% (Nov 2023)
- Worst month: −5.49% (Mar 2026)
C000201974 Fund Flows
Monthly money in and out of BlackRock LifePath Index 2045 Fund, from SEC Form N-PORT.
- 12-month net flow: −$25.8M
- 12-month gross sales (incl. reinvestments): $2.2B
- Sales ÷ redemptions: 0.99×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $128.7M | $163.8M | −$35.1M |
| May 2026 | $124.9M | $138.2M | −$13.3M |
| Apr 2026 | $139.1M | $249.1M | −$110.0M |
| Mar 2026 | $172.0M | $248.6M | −$76.6M |
| Feb 2026 | $135.1M | $218.6M | −$83.5M |
| Jan 2026 | $171.2M | $230.1M | −$58.9M |
| Dec 2025 | $424.9M | $175.8M | $249.1M |
| Nov 2025 | $98.4M | $121.0M | −$22.6M |
| Oct 2025 | $141.0M | $171.7M | −$30.7M |
| Sep 2025 | $308.4M | $113.9M | $194.5M |
| Aug 2025 | $121.1M | $155.0M | −$33.9M |
| Jul 2025 | $197.7M | $202.4M | −$4.7M |
C000201974 Assets Under Management
Net assets of BlackRock LifePath Index 2045 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $11.47B |
| 2026-03-31 | $10.43B |
| 2025-12-31 | $10.74B |
| 2025-09-30 | $10.56B |
| 2025-06-30 | $9.76B |
| 2025-03-31 | $8.99B |
| 2024-12-31 | $9.00B |
| 2024-09-30 | $9.09B |
| 2024-06-30 | $8.38B |
| 2024-03-31 | $8.17B |
| 2023-12-31 | $7.47B |
| 2023-09-30 | $6.57B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.